IN BRIEF: GSK adds Oxford University medical science head to board

GSK PLC - London-based pharmaceutical company - Hires Gavin Screaton as a non-executive director, ...

Alliance News 21 February, 2025 | 9:00AM
Email Form Facebook Twitter LinkedIn RSS

GSK PLC - London-based pharmaceutical company - Hires Gavin Screaton as a non-executive director, joining the board on May 1. Screaton is head of the Medical Sciences Division at the University of Oxford. He is "an expert in the field of immunology and infectious diseases, two areas of science critical to GSK," it says. Screaton replaces Jesse Goodman, who will step down at GSK's annual general meeting in May, after nine years on the board. GSK hasn't yet announced a date for its 2025 AGM. In 2024, it was held on May 8.

Current stock price: 1,408.50 pence

12-month change: down 15%

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
GSK PLC 1,429.00 GBX -1.24

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures